• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质质谱的快速准确电荷态去卷积

Fast and Accurate Charge State Deconvolution of Protein Mass Spectra.

作者信息

Durbin Kenneth R, Robey Matthew T, Greer Joseph B, Fellers Ryan T, Bailey Aaron O

机构信息

Proteinaceous, Inc., Evanston, Illinois 60201, United States.

AbCellera Biologics, Inc., Vancouver, British Columbia V5Y 1G6, Canada.

出版信息

Anal Chem. 2025 Jul 22;97(28):14964-14973. doi: 10.1021/acs.analchem.5c00288. Epub 2025 Jul 7.

DOI:10.1021/acs.analchem.5c00288
PMID:40622281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12291047/
Abstract

Charge state deconvolution is essential for efficient and effective protein mass spectrometry analysis. High-quality mass profiling is necessary to determine which proteoforms are present in protein samples and their relative abundances. In the pursuit of a well-rounded deconvolution solution, we detail an iterative charge state deconvolution algorithm named kDecon that has been tuned to provide high accuracy in its mass results while also delivering superb sensitivity toward lower abundance proteoforms in complex spectra. Here, the performance of kDecon as a mass determination algorithm for both targeted antibody and high-throughput proteomics analysis was benchmarked against existing deconvolution solutions. While the different deconvolution routines all proved robust for detecting the highest abundance protein species, kDecon ultimately showcased best-in-class precision for lower abundance proteoform mass profiling. Furthermore, kDecon results had up to 7-fold fewer false positives and simultaneously exhibited at least 20-fold speed improvements over the other algorithms. Overall, these deconvolution advances will contribute to enabling both routine and thorough intact mass profiling studies for biotherapeutics as well as improving the proteome coverage of top-down proteomics experiments.

摘要

电荷态去卷积对于高效且有效的蛋白质质谱分析至关重要。高质量的质谱剖析对于确定蛋白质样品中存在哪些蛋白质异构体及其相对丰度是必要的。在寻求全面的去卷积解决方案的过程中,我们详细介绍了一种名为kDecon的迭代电荷态去卷积算法,该算法经过调整,在质量结果上具有高精度,同时对复杂光谱中较低丰度的蛋白质异构体也具有出色的灵敏度。在此,将kDecon作为靶向抗体和高通量蛋白质组学分析的质量测定算法的性能与现有的去卷积解决方案进行了基准测试。虽然不同的去卷积程序在检测最高丰度蛋白质种类方面都证明是可靠的,但kDecon最终在较低丰度蛋白质异构体的质谱剖析方面展现出一流的精度。此外,kDecon的结果假阳性减少了多达7倍,同时与其他算法相比,速度提高了至少20倍。总体而言,这些去卷积方面的进展将有助于实现生物治疗药物的常规和全面完整质谱剖析研究,并提高自上而下蛋白质组学实验的蛋白质组覆盖率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e01/12291047/5331cff9fe3d/ac5c00288_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e01/12291047/8792108a1d6c/ac5c00288_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e01/12291047/55303ab4b8c0/ac5c00288_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e01/12291047/ac59335312f9/ac5c00288_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e01/12291047/5331cff9fe3d/ac5c00288_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e01/12291047/8792108a1d6c/ac5c00288_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e01/12291047/55303ab4b8c0/ac5c00288_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e01/12291047/ac59335312f9/ac5c00288_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e01/12291047/5331cff9fe3d/ac5c00288_0004.jpg

相似文献

1
Fast and Accurate Charge State Deconvolution of Protein Mass Spectra.蛋白质质谱的快速准确电荷态去卷积
Anal Chem. 2025 Jul 22;97(28):14964-14973. doi: 10.1021/acs.analchem.5c00288. Epub 2025 Jul 7.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.

本文引用的文献

1
Establishing a Top-Down Proteomics Platform on a Time-of-Flight Instrument with Electron-Activated Dissociation.在配备电子激活解离功能的飞行时间仪器上建立自上而下的蛋白质组学平台。
J Proteome Res. 2025 Mar 7;24(3):1230-1240. doi: 10.1021/acs.jproteome.4c00874. Epub 2025 Feb 17.
2
"Small is beautiful" - Examining reliable determination of low-abundant therapeutic antibody glycovariants.“小即美”——探讨低丰度治疗性抗体糖变体的可靠测定方法。
J Pharm Anal. 2024 Oct;14(10):100982. doi: 10.1016/j.jpha.2024.100982. Epub 2024 Apr 26.
3
Top-down mass spectrometry analysis of capsid proteins of recombinant adeno-associated virus using multiple ion activations and proton transfer charge reduction.
使用多重离子激活和质子转移电荷降低技术对重组腺相关病毒衣壳蛋白进行自上而下的质谱分析。
Proteomics. 2025 Mar;25(5-6):e2400223. doi: 10.1002/pmic.202400223. Epub 2024 Sep 5.
4
Filling the gaps in peptide maps with a platform assay for top-down characterization of purified protein samples.采用平台检测法对纯化蛋白样品进行自上而下的分析,以填补肽图中的空白。
Proteomics. 2024 Nov;24(21-22):e2400036. doi: 10.1002/pmic.202400036. Epub 2024 Jul 14.
5
High-Throughput Covalent Modifier Screening with Acoustic Ejection Mass Spectrometry.高通量共价修饰剂筛选的声喷射质谱法。
J Am Chem Soc. 2024 Jul 24;146(29):19792-19799. doi: 10.1021/jacs.4c02377. Epub 2024 Jul 12.
6
Mass spectrometry characterization of antibodies at the intact and subunit levels: from targeted to large-scale analysis.完整和亚基水平抗体的质谱表征:从靶向分析到大规模分析
Int J Mass Spectrom. 2023 Oct;492. doi: 10.1016/j.ijms.2023.117117. Epub 2023 Aug 17.
7
Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients.深入黑暗血清蛋白质组:重症 COVID-19 患者 IgG1 和 IgA1 抗体库的个性化特征
Mol Cell Proteomics. 2024 Jan;23(1):100690. doi: 10.1016/j.mcpro.2023.100690. Epub 2023 Dec 6.
8
Advancing Intact Protein Quantitation with Updated Deconvolution Routines.推进更新的去卷积程序的完整蛋白质定量分析。
Anal Chem. 2023 Oct 10;95(40):14954-14962. doi: 10.1021/acs.analchem.3c02345. Epub 2023 Sep 26.
9
ProSight Native: Defining Protein Complex Composition from Native Top-Down Mass Spectrometry Data.ProSight Native:从天然的自上而下质谱数据定义蛋白质复合物组成。
J Proteome Res. 2023 Aug 4;22(8):2660-2668. doi: 10.1021/acs.jproteome.3c00171. Epub 2023 Jul 12.
10
Production and characterization of an AAV1-VP3-only capsid: An analytical benchmark standard.仅含 AAV1-VP3 的衣壳的生产与特性分析:一种分析基准标准。
Mol Ther Methods Clin Dev. 2023 May 9;29:460-472. doi: 10.1016/j.omtm.2023.05.002. eCollection 2023 Jun 8.